Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

DMT Models the Near-Death Experience
Christopher Timmermann, Leor Roseman, L. Williams, et al.
Frontiers in Psychology (2018) Vol. 9
Open Access | Times Cited: 190

Showing 1-25 of 190 citing articles:

REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics
Robin Carhart‐Harris, Karl Friston
Pharmacological Reviews (2019) Vol. 71, Iss. 3, pp. 316-344
Open Access | Times Cited: 770
Neural correlates of the DMT experience assessed with multivariate EEG
Christopher Timmermann, Leor Roseman, Michael Schartner, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 246
Human brain effects of DMT assessed via EEG-fMRI
Christopher Timmermann, Leor Roseman, Sharad Haridas, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 13
Open Access | Times Cited: 129
Psychedelics alter metaphysical beliefs
Christopher Timmermann, Hannes Kettner, Chris Letheby, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 127
From many to (n)one: Meditation and the plasticity of the predictive mind
Ruben Laukkonen, Heleen A. Slagter
Neuroscience & Biobehavioral Reviews (2021) Vol. 128, pp. 199-217
Open Access | Times Cited: 115
Towards psychedelic apprenticeship: Developing a gentle touch for the mediation and validation of psychedelic-induced insights and revelations
Christopher Timmermann, Rosalind Watts, David Dupuis
Transcultural Psychiatry (2022) Vol. 59, Iss. 5, pp. 691-704
Open Access | Times Cited: 75
Game changers in science and technology - now and beyond
Ulrich A. K. Betz, Loukik Arora, R.A. Assal, et al.
Technological Forecasting and Social Change (2023) Vol. 193, pp. 122588-122588
Open Access | Times Cited: 67
Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants
Severin B. Vogt, Laura Ley, Livio Erne, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 48
Pivotal mental states
Ari Brouwer, Robin Carhart‐Harris
Journal of Psychopharmacology (2020) Vol. 35, Iss. 4, pp. 319-352
Open Access | Times Cited: 111
Absorption and spiritual experience: A review of evidence and potential mechanisms
Michael Lifshitz, Michiel van Elk, T. M. Luhrmann
Consciousness and Cognition (2019) Vol. 73, pp. 102760-102760
Closed Access | Times Cited: 108
Survey of entity encounter experiences occasioned by inhaled N,N-dimethyltryptamine: Phenomenology, interpretation, and enduring effects
Alan K. Davis, John Clifton, Eric G Weaver, et al.
Journal of Psychopharmacology (2020) Vol. 34, Iss. 9, pp. 1008-1020
Open Access | Times Cited: 102
Mystical and Other Alterations in Sense of Self: An Expanded Framework for Studying Nonordinary Experiences
Ann Taves
Perspectives on Psychological Science (2020) Vol. 15, Iss. 3, pp. 669-690
Open Access | Times Cited: 94
Biosynthesis and Extracellular Concentrations of N,N-dimethyltryptamine (DMT) in Mammalian Brain
Jon G. Dean, Tiecheng Liu, Sean Huff, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 84
Neurochemical models of near-death experiences: A large-scale study based on the semantic similarity of written reports
Charlotte Martial, Héléna Cassol, Vanessa Charland‐Verville, et al.
Consciousness and Cognition (2019) Vol. 69, pp. 52-69
Open Access | Times Cited: 81
Near-Death Experience as a Probe to Explore (Disconnected) Consciousness
Charlotte Martial, Héléna Cassol, Steven Laureys, et al.
Trends in Cognitive Sciences (2020) Vol. 24, Iss. 3, pp. 173-183
Open Access | Times Cited: 70
Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential?
Rita Kočárová, Jiřı́ Horáček, Robin Carhart‐Harris
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 65
Guidelines and standards for the study of death and recalled experiences of death––a multidisciplinary consensus statement and proposed future directions
Sam Parnia, Stephen G. Post, Matthew T. Lee, et al.
Annals of the New York Academy of Sciences (2022) Vol. 1511, Iss. 1, pp. 5-21
Open Access | Times Cited: 46
Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dying
Mary M. Sweeney, Sandeep M. Nayak, Ethan Hurwitz, et al.
PLoS ONE (2022) Vol. 17, Iss. 8, pp. e0271926-e0271926
Open Access | Times Cited: 37
Pharmacokinetics of N,N-dimethyltryptamine in Humans
Meghan Good, Zelah Joel, Tiffanie Benway, et al.
European Journal of Drug Metabolism and Pharmacokinetics (2023) Vol. 48, Iss. 3, pp. 311-327
Open Access | Times Cited: 30
Effects of DMT on mental health outcomes in healthy volunteers
Christopher Timmermann, Richard J. Zeifman, David Erritzøe, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Giving Consent to the Ineffable
Daniel Villiger
Neuroethics (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 10
Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression
Johannes G. Ramaekers, Johannes T. Reckweg, Natasha L. Mason
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 33-46
Closed Access | Times Cited: 1
Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics
Sam G. Moreton, Luke Szalla, Rachel E. Menzies, et al.
Psychopharmacology (2019) Vol. 237, Iss. 1, pp. 21-32
Closed Access | Times Cited: 66
Neural and subjective effects of inhaled N,N-dimethyltryptamine in natural settings
Carla Pallavicini, Federico Cavanna, Federico Zamberlán, et al.
Journal of Psychopharmacology (2021) Vol. 35, Iss. 4, pp. 406-420
Closed Access | Times Cited: 46
The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges
Rafael G. dos Santos, José Carlos Bouso, Juliana Mendes Rocha, et al.
Risk Management and Healthcare Policy (2021) Vol. Volume 14, pp. 901-910
Open Access | Times Cited: 46
Page 1 - Next Page

Scroll to top